Stable Isotope Labelled Urelumab Biosimilar – Anti-TNFRSF9/CD137 mAb – Research Grade

Reference: PX-TA1265-SIL-1MG
Size

Brand

Product type

Clonality

Expression system

Applications

Product nameStable Isotope Labelled Urelumab Biosimilar - Anti-TNFRSF9/CD137 mAb - Research Grade
SourceCAS 934823-49-1
SpeciesHomo sapiens
Expression systemMammalian cells
Purity>95%
BufferPBS buffer PH7.5
Delivery conditionBlue Ice
Delivery Time3-5 days if in stock; 5-8 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsMS
Aliases /SynonymsBMS-663513
ReferencePX-TA1265-SIL
Related ProductsPX-P4059
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG4-kappa
ClonalityMonoclonal Antibody
FormatLyophilized
LabellingArginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99%
Isotopic Enrichment99%
Stability1 year

Description of Urelumab Biosimilar - Anti-TNFRSF9/CD137 mAb - Research Grade

General information on Anti-TNFRSF9/CD137 [Homo sapiens] (Urelumab) Monoclonal Antibody

Urelumab is a human antibody targeting CD137. Urelumab has been investigated for the treatment of Leukemia, Multiple Myeloma, Malignant Tumors, Cancer – Solid Tumors and B-Cell Non-Hodgkin’s Lymphoma.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Stable Isotope Labelled Urelumab Biosimilar – Anti-TNFRSF9/CD137 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products